ATE196290T1 - Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatoren - Google Patents
Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatorenInfo
- Publication number
- ATE196290T1 ATE196290T1 AT95941202T AT95941202T ATE196290T1 AT E196290 T1 ATE196290 T1 AT E196290T1 AT 95941202 T AT95941202 T AT 95941202T AT 95941202 T AT95941202 T AT 95941202T AT E196290 T1 ATE196290 T1 AT E196290T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrazinecarbonic
- pyridine
- cell growth
- acid derivatives
- growth regulators
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
- 239000002253 acid Substances 0.000 title 1
- 230000010261 cell growth Effects 0.000 title 1
- 239000003630 growth substance Substances 0.000 title 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 150000003216 pyrazines Chemical class 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9425730.0A GB9425730D0 (en) | 1994-12-20 | 1994-12-20 | Compounds |
| PCT/GB1995/002977 WO1996019457A1 (en) | 1994-12-20 | 1995-12-20 | Pyridine and pyrazinedicarboxylic-acid derivatives as cell proliferation regulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE196290T1 true ATE196290T1 (de) | 2000-09-15 |
Family
ID=10766245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95941202T ATE196290T1 (de) | 1994-12-20 | 1995-12-20 | Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatoren |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5972926A (de) |
| EP (1) | EP0799208B1 (de) |
| AT (1) | ATE196290T1 (de) |
| AU (1) | AU4268696A (de) |
| DE (1) | DE69518857T2 (de) |
| ES (1) | ES2150021T3 (de) |
| GB (1) | GB9425730D0 (de) |
| WO (1) | WO1996019457A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9425730D0 (en) * | 1994-12-20 | 1995-02-22 | Nycomed Pharma As | Compounds |
| EP0958283A1 (de) * | 1997-01-27 | 1999-11-24 | Nycomed Austria GmbH | Neue verbindungen mit hämoregulatorischer wirkung |
| US6184241B1 (en) * | 1998-08-24 | 2001-02-06 | Kansas State University Research Foundation | Aspartic protease inhibitors |
| US6340683B1 (en) | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
| US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
| DK1183245T3 (da) | 1999-04-22 | 2007-09-24 | Lundbeck & Co As H | Selektive NPY(Y5)-antagonister |
| US6218408B1 (en) | 1999-06-30 | 2001-04-17 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
| US6222040B1 (en) | 1999-06-30 | 2001-04-24 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
| US6225330B1 (en) | 1999-06-30 | 2001-05-01 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
| US7273880B2 (en) | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
| US6214853B1 (en) | 1999-06-30 | 2001-04-10 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
| FR2843590B1 (fr) | 2002-08-14 | 2007-10-05 | Prestwick Scient Capital Inc | Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique |
| US20070270590A1 (en) * | 2006-04-20 | 2007-11-22 | Marioara Mendelovici | Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
| US20080015197A1 (en) * | 2006-06-26 | 2008-01-17 | Alex Mainfeld | Process for the preparatrion of zopiclone |
| TW200846340A (en) * | 2007-01-31 | 2008-12-01 | Teva Pharma | Methods for preparing eszopiclone |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL104323A0 (en) * | 1992-01-10 | 1993-05-13 | Smithkline Beecham Corp | Hemoregulatory peptides |
| GB9211677D0 (en) * | 1992-06-02 | 1992-07-15 | Nycomed Bioreg As | Peptide compounds |
| GB9211668D0 (en) * | 1992-06-02 | 1992-07-15 | Nycomed Bioreg As | Peptide compounds |
| GB9314200D0 (en) * | 1993-07-09 | 1993-08-18 | Hafslund Nycomed As | Peptide compounds |
| DE69420044T2 (de) * | 1993-10-29 | 2000-03-23 | Smithkline Beecham Corp., King Of Prussia | Blutregulierende peptide |
| GB9324691D0 (en) * | 1993-12-01 | 1994-01-19 | Hafslund Nycomed As | Peptide compounds |
| GB9425730D0 (en) * | 1994-12-20 | 1995-02-22 | Nycomed Pharma As | Compounds |
-
1994
- 1994-12-20 GB GBGB9425730.0A patent/GB9425730D0/en active Pending
-
1995
- 1995-12-20 DE DE69518857T patent/DE69518857T2/de not_active Expired - Lifetime
- 1995-12-20 WO PCT/GB1995/002977 patent/WO1996019457A1/en not_active Ceased
- 1995-12-20 AT AT95941202T patent/ATE196290T1/de active
- 1995-12-20 EP EP95941202A patent/EP0799208B1/de not_active Expired - Lifetime
- 1995-12-20 ES ES95941202T patent/ES2150021T3/es not_active Expired - Lifetime
- 1995-12-20 US US08/849,456 patent/US5972926A/en not_active Expired - Fee Related
- 1995-12-20 AU AU42686/96A patent/AU4268696A/en not_active Abandoned
-
1999
- 1999-08-20 US US09/377,776 patent/US6124298A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996019457A1 (en) | 1996-06-27 |
| GB9425730D0 (en) | 1995-02-22 |
| ES2150021T3 (es) | 2000-11-16 |
| US5972926A (en) | 1999-10-26 |
| EP0799208B1 (de) | 2000-09-13 |
| US6124298A (en) | 2000-09-26 |
| DE69518857D1 (de) | 2000-10-19 |
| AU4268696A (en) | 1996-07-10 |
| DE69518857T2 (de) | 2001-04-26 |
| EP0799208A1 (de) | 1997-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0741710T3 (da) | Chlorpyrimidin-mellemprodukter | |
| DE69518857D1 (de) | Pyridin- und pyrazindicarbonsäurederivate als zellwachstumsregulatoren | |
| AU9536898A (en) | 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein | |
| PL322015A1 (en) | Derivatives of hydroxylamine useful as compounds enhancing production of accompanying molecular protein and ethod of obtaining them | |
| MY109143A (en) | Sulfonamido-and sulfonamidocarbonylpyridine 2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals | |
| PT839154E (pt) | Peptidos e composicoes biologicamente activos sua utilizacao | |
| DE69709458D1 (de) | Verwendung des glialen, neurotrophen faktors (gdnf) zur behandlung von gehörstörungen | |
| HUT76511A (en) | Benzoyl derivatives, preparation and use thereot | |
| DE69702705D1 (de) | Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren | |
| ATE16489T1 (de) | Aroylimidazolone. | |
| MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
| YU113391A (sh) | 2,4 i 2,5 substituirani piridin-n oksidi i postupak za njihovu proizvodnju | |
| CA2157836A1 (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses | |
| DE69535081D1 (de) | Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis | |
| YU13699A (sh) | Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože | |
| NO991734L (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
| BG101535A (en) | 1,4-diaryl-2-fluoro-2-butene insecticide and acaricidal formulations | |
| NZ335057A (en) | Pentaerythritol derivatives, their production and use and intermediates for their synthesis | |
| MX9701764A (es) | Derivados de imidoacidos. | |
| DK1051404T3 (da) | Substituerede phenyluraciler med herbicid virkning | |
| AU6722498A (en) | Disubstituted biphenyloxazolines | |
| NZ323207A (en) | Hemoregulatory compounds | |
| ATE124398T1 (de) | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung. | |
| RO116403B1 (ro) | Derivaţi ai teofilinei şi teobrominei şi procedeu de preparare | |
| DE59208712D1 (de) | Neue cytarabin-derivate, ihre herstellung und verwendung |